TUB-newsletter-top-banner-new
 

Please feel free forward to your colleagues & fellow researchers to share the news of our journal

***
TUB-cover-2021 new

Indexed in: DOAJ PubMed/MEDLINE Scopus

Dear Colleague,

Welcome to the newsletter of Tumor Biology, the official journal of the International Society of Oncology and BioMarkers. Content is published in this open access journal on a rolling basis, in one volume and issue per year.

We are now delighted to share a Call for Papers for an upcoming new special issue on Lung Cancer Tumor Markers, as well as highlighting a new research article published in Volume 44 during the second quarter of this year (Q2, Apr–Jun 2022), sharing the most read recent content, and providing details of how to submit your research to the journal.

Looking forward to working with you.

Kind regards,

Editor-in-Chief
Magdalena Chechlinska, PhD
TumorBiology.Editor@pib-nio.pl

new-blue-bar

Tumor Biology / Lung Cancer Tumor Markers

Call for Papers for Upcoming Special Issue

Get 50% reduction on the open access fee!

We are pleased to announce an upcoming special issue on Lung Cancer Tumor Markers. The guest editors, Stefan Holdenrieder (Technical University Munich), Huub van Rossum (Netherlands Cancer Institute), and Michel van den Heuvel (Radboud University Medical Center), seek submissions from now until October 31, 2022. These can be comprehensive reviews, opinion papers, or original research articles that will comprehensively cover the field of tumor marker diagnostics with a focus on lung cancer. For details, view the Call for Papers (PDF) or click the visual below (file will open in a new tab).

new-blue-bar

Tumor Biology Volume 44 / 2022 Q2 Highlighted Article

Content is open access and freely available to read, download and share!

RESEARCH ARTICLE
β-Catenin plus PROX1 immunostaining stratifies disease progression and patient survival in neoadjuvant-treated pancreatic cancer
Eurola, Annika | Ristimäki, Ari | Mustonen, Harri | Nurmi, Anna-Maria | Hagström, Jaana | Kallio, Pauliina | Alitalo, Kari | Haglund, Caj | Seppänen, Hanna

Backgoround: The function and expression of Wnt/β-catenin signaling and PROX1 in pancreatic cancer following neoadjuvant treatment are not understood. It is not known whether the cytoplasmic expression of these markers correlates with survival in neoadjuvant-treated pancreatic cancer patients. Thus, we aimed to investigate the expression of β-catenin and PROX1 and their association with survival in neoadjuvant-treated pancreatic cancer in comparison with upfront surgery patients. We also aimed to analyze the differences in the expressions between the different NAT-response groups.

Click the visual below to read the full study:

new-blue-bar

Call For Papers

Publish Where Your Work Will Be Noticed

Submit Today!

As a member of our research community, we would like to invite you to contribute your own articles to the journal.

There are many benefits for contributing authors, including rigorous peer review and rapid processing and online publication (pre-press), and an affordable open access option.

Submit your manuscript online
View the Instructions for Authors
View list of Editorial Board
View full journal contents

new-blue-bar

Most Read Tumor Biology Articles in Q2 2022

Listing the top viewed 2021 and 2022 articles via the IOS Press Content Library

CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242 (Research Article in Volume 43, Online April 2021) – Open Access
Björkman, Kajsa | Mustonen, Harri | Kaprio, Tuomas | Kekki, Henna | Pettersson, Kim | Haglund, Caj | Böckelman, Camilla

The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor (Review Article in Volume 43, Online August 2021) – Open Access
Epstein, Richard J.

The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target (Review Article in Volume 43, Online August 2021) – Open Access
Al-Zaidan, Lobna | Mestiri, Sarra | Raza, Afsheen | Merhi, Maysaloun | Inchakalody, Varghese Philipose | Fernandes, Queenie | Taib, Nassiba | Uddin, Shahab | Dermime, Said

A review on the role of CAFs and CAF-derived exosomes in progression and metastasis of digestive system cancers (Review Article in Volume 43, Online August 2021) – Open Access
Zarin, Bahare | Rafiee, Laleh | Daneshpajouhnejad, Parnaz | Haghjooy Javanmard, Shaghayegh

Early prediction of prostate cancer biochemical recurrence and identification of disease persistence using PSA isoforms and human kallikrein-2 (Research Article in Volume 43, Online August 2021) – Open Access
Do Carmo Silva, Joana | Vesely, Stepan | Luksanova, Hana | Prusa, Richard | Babjuk, Marko

Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors (Research Article in Volume 43, Online December 2021) – Open Access
Blackman, Alexandra | Mitchell, Jessica | Rowswell-Turner, Rachael | Singh, Rakesh | Kim, Kyu Kwang | Eklund, Elizabeth | Skates, Steven | Bast, Robert C. | et al.

Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy (Research Article in Volume 44, Online February 2022) – Open Access
Piper, Thomas B. | Nielsen, Hans J. | Christensen, Ib Jarle

new-blue-bar

Please Share Tumor Biology News With Your Colleagues

Help Spread News of this Open Access Journal!

If you know of any colleagues or fellow researchers who are not yet signed up to receive news from Tumor Biology, we invite you to share this mailing with them.

Want to sign up for news? Click on the visual below or access the sign-up link here.

new-blue-bar
***

You are receiving this mailing as you are signed up to receive news from TUB.
You can unsubscribe or alter your preferences at any time by clicking the links below
.

If you would like to receive more NEWS FROM IOS PRESS, go here

 
 
Powered by Mad Mimi®A GoDaddy® company